Professor Toshiaki Furukawa from Department of Health Promotion and Human Behavior and his research collaborators including Dr. Luis Farhat from Universidade de São Paulo conducted dose-response meta-analysis and recommended that practitioners should cautiously consider unlicensed doses of stimulants when administering to adults with attention-deficit/hyperactivity disorder (ADHD).

Farhat LC, Flores JM, Avila-Quintero VJ, Polanczyk GV, Cipriani A, Furukawa TA, Bloch MH & Cortese S (2023) Treatment Outcomes With Licensed and Unlicensed Stimulant Doses for Adults With Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis. JAMA Psychiatry.
https://doi.org/10.1001/jamapsychiatry.2023.3985

Furthermore, Professor Furukawa and his research collaborators including Dr. Davide Papola from Harvard University conducted network meta-analysis to evaluate various psychotherapies for generalized anxiety disorder in Adults. They concluded that cognitive behavior therapies should be considered the first-line choice for treatment of generalized anxiety disorder in the perspective of effectiveness and acceptability.

Papola D, Miguel C, Mazzaglia M, Franco P, Tedeschi F, Romero SA, Patel AR, Ostuzzi G, Gastaldon C, Karyotaki E, Harrer M, Purgato M, Sijbrandij M, Patel V, Furukawa TA, Cuijpers P & Barbui C (2023) Psychotherapies for Generalized Anxiety Disorder in Adults: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials. JAMA Psychiatry.
https://doi.org/10.1001/jamapsychiatry.2023.3971